Corcept, Optime file reply for dismissing Teva's US antitrust claims
MLex Summary: Corcept Therapeutics and Optime Care filed a reply in support of their motion to dismiss monopolization claims from Teva Pharmaceuticals, saying that Teva never explains why it chose to...To view the full article, register now.
Already a subscriber? Click here to view full article